Viking Therapeutics, Inc.

VKTX·NasdaqCM·Healthcare
Compare
27.97+1.88 (+7.21%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market27.81−0.16 (−0.57%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close26.09
Open26.91
Day range26.0928.00
52-week range23.8243.15
Off day high−0.11%
Off 52-week high−35.18%
Volume4.03M
Avg. volume (3M)4.89M
Market cap3.57B
EPS (TTM)-5.42
Forward P/E-5.46
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.75
Shares outstanding127.52M
Short interest21.06% of float
Earnings dateOct 28, 2026
Analyst target95.32
Profit margin0.00%

Against its peers

Compare in full ›
VKTX SEPN VRDN GPCR BHVN MBX
Market cap 3.57B 2.23B 3.30B 1.45B 2.30B 2.53B
P/E (TTM) — — — — — —
Forward P/E -5.5 -24.7 -10.7 -9.6 -8.2 -13.2
Price/book 6.1 5.7 6.8 1.1 -23.4 6.1
Dividend yield — — — — — —
1-year change −24.95% +154.68% +5.65% −39.17% +78.66% +112.13%
Today +7.21% +9.57% +15.53% +0.05% −2.37% −4.58%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All VKTX news ›
Seeking Alpha·Positive

Viking Therapeutics: A Strong Injection, A Scaled-Back Pill

Viking Therapeutics is advancing VK2735, a dual GLP-1/GIP agonist for obesity, with Phase 3 injection results expected in 2027. Read why VKTX stock is a hold. - Viking Therapeutics is advancing VK2735, a dual GLP-1/GIP agonist for obesity,…

From the 4Search news index, newest first.

In the news

44mentions in 30 days
35with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 44 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance